KK
VKTX icon

KLP Kapitalforvaltning’s Viking Therapeutics VKTX Stock Holding History

KLP Kapitalforvaltning’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$975K Buy
25,000
+1,400
+6% +$45.2K ﹤0.01% 1145
2026
Q1 		$768K Buy
23,600
+700
+3% +$22.5K ﹤0.01% 1178
2025
Q4 		$806K Buy
22,900
+300
+1% +$10.6K ﹤0.01% 1152
2025
Q3 		$594K Hold
22,600
– – ﹤0.01% 1308
2025
Q2 		$599K Buy
22,600
+1,900
+9% +$50K ﹤0.01% 1269
2025
Q1 		$500K Hold
20,700
– – ﹤0.01% 1301
2024
Q4 		$833K Buy
+20,700
New +$1.18M ﹤0.01% 1071

Other funds holding VKTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

KLP Kapitalforvaltning's VKTX Position: Q2 2026 in Review

KLP Kapitalforvaltning increased its Viking Therapeutics (VKTX) stake by 5.9% in Q2 2026, buying an estimated $45.2K and bringing the position to 25,000 shares worth $975K. The position accounts for ﹤0.01% of the portfolio, ranked #1145.

KLP Kapitalforvaltning first reported a position in VKTX in Q4 2024 and has held it in 7 quarters since. 432 funds tracked by Wall St. Rank hold VKTX as of Q2 2026.

  • KLP Kapitalforvaltning held 25,000 shares of Viking Therapeutics worth $975K as of Q2 2026.
  • KLP Kapitalforvaltning bought 1,400 Viking Therapeutics shares in Q2 2026, an estimated $45.2K.
  • Viking Therapeutics made up ﹤0.01% of KLP Kapitalforvaltning's portfolio in Q2 2026, its #1145 holding.
  • KLP Kapitalforvaltning first reported a position in Viking Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • 432 funds tracked by Wall St. Rank held Viking Therapeutics as of Q2 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q2 2026, filed 12 Aug 2026.